| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Science and Biomedical Technology, University of Udine, 2 Morpurgo Hofmann Research Laboratory on Aging, and 3 Department of Pathology and Experimental and Clinical Medicine, Internal Medicine, University of Udine, 33100 Udine, Italy
To explore the effect of fluctuating glucose on endothelial cells, human umbilical vein endothelial cells were incubated for 14 days in media containing different glucose concentrations: 5 mmol/l, 20 mmol/l, or a daily alternating 5 or 20 mmol/l glucose. Apoptosis was studied by different methods: viability assay, cell cycle analysis, DNA fragmentation, and morphological analysis. Furthermore, the levels of Bcl-2 and Bax, well known proteins involved in apoptosis, were evaluated. Stable high glucose induced apoptosis in human umbilical vein endothelial cells, a phenomenon accompanied by a significant decrease of Bcl-2 and a simultaneous increase of Bax expression. However, apoptosis was enhanced in human umbilical vein endothelial cells exposed to intermittent, rather than constant, high glucose concentration. In this condition, Bcl-2 was not detectable, whereas Bax expression was significantly enhanced. These findings suggest that variability in glycemic control could be more deleterious to endothelial cells than a constant high concentration of glucose.
intermittent glucose; endothelium; apoptosis; Bcl-2 protein; Bax protein
This article has been cited by other articles:
|
|
 |
|
  B. Collier, L. A. Dossett, A. K. May, and J. J. Diaz Glucose Control and the Inflammatory Response Nutr Clin Pract, February 1, 2008; 23(1): 3 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Wolever, A. L Gibbs, C. Mehling, J.-L. Chiasson, P. W Connelly, R. G Josse, L. A Leiter, P. Maheux, R. Rabasa-Lhoret, N W. Rodger, et al. The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein Am. J. Clinical Nutrition, January 1, 2008; 87(1): 114 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Meugnier, M. Faraj, S. Rome, G. Beauregard, A. Michaut, V. Pelloux, J.-L. Chiasson, M. Laville, K. Clement, H. Vidal, et al. Acute Hyperglycemia Induces a Global Downregulation of Gene Expression in Adipose Tissue and Skeletal Muscle of Healthy Subjects Diabetes, April 1, 2007; 56(4): 992 - 999. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Azuma, R. Kawamori, Y. Toyofuku, Y. Kitahara, F. Sato, T. Shimizu, K. Miura, T. Mine, Y. Tanaka, M. Mitsumata, et al. Repetitive Fluctuations in Blood Glucose Enhance Monocyte Adhesion to the Endothelium of Rat Thoracic Aorta Arterioscler. Thromb. Vasc. Biol., October 1, 2006; 26(10): 2275 - 2280. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Asbun and F. J. Villarreal The Pathogenesis of Myocardial Fibrosis in the Setting of Diabetic Cardiomyopathy J. Am. Coll. Cardiol., February 21, 2006; 47(4): 693 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M E Tushuizen, M Diamant, and R J Heine Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes Postgrad. Med. J., January 1, 2005; 81(951): 1 - 6. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. S. Polhill, S. Saad, P. Poronnik, G. R. Fulcher, and C. A. Pollock Short-term peaks in glucose promote renal fibrogenesis independently of total glucose exposure Am J Physiol Renal Physiol, August 1, 2004; 287(2): F268 - F273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. McGinn, P. Poronnik, M. King, E. D. M. Gallery, and C. A. Pollock High glucose and endothelial cell growth: novel effects independent of autocrine TGF-beta 1 and hyperosmolarity Am J Physiol Cell Physiol, June 1, 2003; 284(6): C1374 - C1386. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
